[Corrigendum] Isolinderalactone enhances the inhibition of SOCS3 on STAT3 activity by decreasing miR‑30c in breast cancer.
1/5 보강
Subsequently to the publication of the above paper, an interested reader drew to the authors' attention that, regarding the western blot data shown in Fig.
APA
Yen MC, Shih YC, et al. (2026). [Corrigendum] Isolinderalactone enhances the inhibition of SOCS3 on STAT3 activity by decreasing miR‑30c in breast cancer.. Oncology reports, 55(2). https://doi.org/10.3892/or.2025.9041
MLA
Yen MC, et al.. "[Corrigendum] Isolinderalactone enhances the inhibition of SOCS3 on STAT3 activity by decreasing miR‑30c in breast cancer.." Oncology reports, vol. 55, no. 2, 2026.
PMID
41456436 ↗
Abstract 한글 요약
Subsequently to the publication of the above paper, an interested reader drew to the authors' attention that, regarding the western blot data shown in Fig. 4 on p. 1361, the lower of the control GAPDH blots in Fig. 4A and B appeared to be essentially the same (albeit the blots were more exposed in Fig. 4B), even though the experimental conditions in the two figure parts were reported to be different. The authors were able to re‑examine their original data files, and realized that the western blot image for Fig. 4B had inadverently been selected incorrectly. The revised version of Fig. 4, now containing the correct data for the lower GAPDH blots in Fig. 4B, is shown below. Note that the correction made to this figure does not affect the overall conclusions reported in the paper. The authors are grateful to the Editor of for allowing them the opportunity to publish this Corrigendum, and apologize to the readership for any inconvenience caused. [Oncology Reports 35: 1356‑1364, 2016; DOI: 10.3892/or.2015.4503].
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
📖 전문 본문 읽기 PMC JATS · ~2 KB · 영문
Oncol Rep 35: 1356–1364, 2016; DOI: 10.3892/or.2015.4503
Subsequently to the publication of the above paper, an interested reader drew to the authors' attention that, regarding the western blot data shown in Fig. 4 on p. 1361, the lower of the control GAPDH blots in Fig. 4A and B appeared to be essentially the same (albeit the blots were more exposed in Fig. 4B), even though the experimental conditions in the two figure parts were reported to be different.
The authors were able to re-examine their original data files, and realized that the western blot image for Fig. 4B had inadverently been selected incorrectly. The revised version of Fig. 4, now containing the correct data for the lower GAPDH blots in Fig. 4B, is shown below. Note that the correction made to this figure does not affect the overall conclusions reported in the paper. The authors are grateful to the Editor of Oncology Reports for allowing them the opportunity to publish this Corrigendum, and apologize to the readership for any inconvenience caused.
Subsequently to the publication of the above paper, an interested reader drew to the authors' attention that, regarding the western blot data shown in Fig. 4 on p. 1361, the lower of the control GAPDH blots in Fig. 4A and B appeared to be essentially the same (albeit the blots were more exposed in Fig. 4B), even though the experimental conditions in the two figure parts were reported to be different.
The authors were able to re-examine their original data files, and realized that the western blot image for Fig. 4B had inadverently been selected incorrectly. The revised version of Fig. 4, now containing the correct data for the lower GAPDH blots in Fig. 4B, is shown below. Note that the correction made to this figure does not affect the overall conclusions reported in the paper. The authors are grateful to the Editor of Oncology Reports for allowing them the opportunity to publish this Corrigendum, and apologize to the readership for any inconvenience caused.
출처: PubMed Central (JATS). 라이선스는 원 publisher 정책을 따릅니다 — 인용 시 원문을 표기해 주세요.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Early local immune activation following intra-operative radiotherapy in human breast tissue.
- Overall survival and prognostic factors in young women with breast cancer: a retrospective cohort study from Southern Thailand.
- Age at First Pregnancy, Adult Weight Gain and Postmenopausal Breast Cancer Risk: The PROCAS Study (United Kingdom).
- Advances in Targeted Therapy for Human Epidermal Growth Factor Receptor 2-Low Tumors: From Trastuzumab to Antibody-Drug Conjugates.
- Structural determinants of glycosaminoglycan oligosaccharides as LL-37 inhibitors in breast cancer.
- Artificial intelligence and breast cancer screening in Serbia: a dual-perspective qualitative study among radiologists and screening-aged women.